Trevena Reports First Quarter 2022 Results and Provides Business Update
May 11, 2022 07:00 ET
|
Trevena, Inc.
OLINVYK refocused commercial strategy initiated mid-Q1 OLINVYK respiratory physiology study demonstrated statistically significant reduced impact on respiratory function compared to IV morphine,...
Trevena to Release First Quarter 2022 Financial Results on May 11, 2022
May 09, 2022 07:00 ET
|
Trevena, Inc.
CHESTERBROOK, Pa., May 09, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...